International Journal of Celiac Disease
ISSN (Print): 2334-3427 ISSN (Online): 2334-3486 Website: Editor-in-chief: Samasca Gabriel
Open Access
Journal Browser
International Journal of Celiac Disease. 2019, 7(1), 13-15
DOI: 10.12691/ijcd-7-1-2
Open AccessArticle

Collagenous Sprue, a Heterogeneous Small Bowel Disorder

Hugh James Freeman1,

1Department of Medicine (Gastroenterology), University of British Columbia, Vancouver, BC, Canada

Pub. Date: March 04, 2019

Cite this paper:
Hugh James Freeman. Collagenous Sprue, a Heterogeneous Small Bowel Disorder. International Journal of Celiac Disease. 2019; 7(1):13-15. doi: 10.12691/ijcd-7-1-2


Collagenous sprue is a disorder characterized by severe diarrhea, progressive malaborption of multiple nutrients, protein depletion and weight loss accompanied by a pathognomic small bowel biopsy lesion characterized by a villus atrophy and a band-like subsepithelial mucosal deposit containing collagen. It has been closely linked to celiac disease, tends to be refractory to treatment and prognosis has been poor with only anecdotes of successful therapy. In recent years, the disorder has been detected in different settings, including early malignancies as a paraneoplastic phenomenon and due to the toxic effects of some medications including non-steroidal anti-inflammatory drugs (NSAIDs) and the angiotensin II receptor antagonist, olmesartan. Here, dramatic reversal to normal of the clinical and pathological changes have been documented so that a medication history is critical in any patient presenting with sprue-like intestinal disease.

collagenous sprue celiac disease non-responsive celiac disease refractory celiac disease refractory sprue olmesartan

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Freeman HJ. Collagenous mucosal inflammatory diseases of the gastrointestinal tract. Gastroenterology 2005; 129: 338-350.
[2]  Lewin KJ, Riddell RH, Weinstein WM. Gastrointestinal Pathology and its Clinical Implications. Volume 2. Igaku-Shoin, New York. 1192: 2, 768-769.
[3]  Schein J. Syndrome of nontropical sprue with hitherto undescribed lesions of the intestine. Gastroenterology 1947; 8: 438-460.
[4]  Hourihane DO. Diarrhea of small bowel origin. The histology of intestinal biopsies. Proc R Soc Med 1963; 56: 1073-1077.
[5]  Weinstein WM, Saunders DR, Tytgat GN, Rubin CE. Collagenous sprue—-an unrecognized type of malabsorption. N Engl J Med 1970; 283: 1297-1301.
[6]  Freeman HJ. Hyposplenism, antiendomysial antibodies and lymphocytic colitis in collagenous sprue. Can J Gastroenterol 1999; 13: 347-350.
[7]  Freeman HJ, Webber DL. Free perforation of the small intestine in collagenous sprue. World J Gastroenterol 2009; 15: 4446-4448.
[8]  Freeman HJ, Davis JE, Myers DM. Complete histological resolution of collagenous. sprue. Can J Gastroenterol 2004; 18: 333-336.
[9]  Doe WF, Evans D, Hobbs JR, Booth CC. Celiac disease, vasculitis, and cryoglobulinemia. Gut 1972; 13: 112-123.
[10]  Robert ME, Ament ME, Weinstein WM. The histologic spectrum and clinical outcome of refractory and unclassified sprue. Am J Sure Pathol 2000; 24: 676-687.
[11]  Freeman HJ. Collagenous sprue associated with an extensive T-cell lymphoma. J Clin Gastroenterol 2003; 36: 144-146.
[12]  Medlicott SA, Beck PL, Loken S, Crabtree T. Synchronous collagenous sprue and enteropathy-type T-cell lymphoma: variants of the same disease. Can J Gastroenterol 2004; 18: 329-332.
[13]  Freeman HJ, Berean KW. Resolution of paraneoplastic collagenous enterocolitis after resection of colon cancer. Can J Gastroenterol 2006; 20: 357-360.
[14]  Vasant DH, Hayes S, Bucknall R, Lal S. Clinical and histological resolution of collagenous sprue following gluten-free diet and discontinuation of non-steroidal anti-inflammatory drugs (NSAIDs). BMJ Case Rep 2013 Aug 28; 2013. Pie: bcr2013200097.
[15]  Rubio-Tapia A, Herman ML, Ludvigsson JF, Kelly DG, Mangan TF, Wu TT, Murray JA. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 2012; 87: 732-738.
[16]  Nielsen JA, Steephen A, Lewin M. Angiotensin-II inhibitor (olmesartan)-induced collagenous sprue with resolution following discontinuation of drug. World J Gastroenterol 2013; 19: 6928-6930.
[17]  Nagashima K, Katsurada T, Sakamoto N. A case of olmesertan-associated sprue-like enteropathy. Clin Gastroenterol Hepatol 2018; 16: xlv-xlvi.
[18]  Freeman HJ. Olmesartan-induced enteropathy. Inter J Celiac Dis 2016:4:24-26.
[19]  Herman ML, Rubio-Tapia A, Wu TT, Murray JA. A case of severe sprue-like enteropathy associated with valsartan. ACG Case Rep J 2015; 2: 92-94.
[20]  Mandavdhare HS, Sharma V, Prasad KK, Kumar A, Rathi M, Rana SS. Telmisartan-induced sprue like enteropathy: a case report and a review of patients using non-olmesartan angiotensin receptor blockers. Intest Res 2017; 15: 419-421.
[21]  Joo M, Shim SH, Chang SH, Kim H, Chi JG, Kim NH. Nodular lymphoid hyperplasia and histologic changes mimicking celiac disease, collagenous sprue, and lymphocytic colitis in a patient with selective IgA deficiency. Pathol Res Pract 2009; 205: 876-880.
[22]  Mandaliya R, Burkart AL, DiMarino AJ, Rattan S, Cohen S. Association between Common variable immunodeficiency and collagenous inflitrative disorder of the Gastrointestinal tract: a series of four patients. Indian J Gastroenterol 2016; 35: 133-138.